Early neonatal hyperbilirubinemia using first day serum bilirubin level
- PMID: 12196683
Early neonatal hyperbilirubinemia using first day serum bilirubin level
Abstract
Objective: To evaluate the predictive value of total serum bilirubin (TSB) < or =6 mg/dl at 24 +/- 6 hr postnatal age in identifying near term and term infants, who do not develop hyperbilirubinemia subsequently.
Design: Prospective study.
Setting: Tertiary care hospital.
Methods: All healthy neonates with gestation > or =35 weeks, in absence of significant illness or Rh hemolysis were included. TSB was estimated at 24 +/- 6 hr by micromethod using spectrophotometry. Infants were followed up clinically every 12 hr till discharge and then after 48 hr. TSB level was estimated again whenever clinical suspicion of jaundice exceeded 10 mg/dl. Primary outcome was defined as presence of hyperbilirubinemia (TSB > or= 17 mg/dl) till day five of age.
Results: Of the 220 infants, 213 (96.8%) were followed up. All infants were exclusively breastfed. Mean age at bilirubin estimation was 24.7 +/- 1.9 hr with mean TSB of 5.9 +/- 1.8 mg/dl. Clinically detectable jaundice was present in 164 (77%) and hyperbilirubinemia occurred in 22 (10.3%) infants. A TSB level of < or = 6 mg/dl at 24 +/- 6 hr was present in 136 (63.8%) infants and only one infant developed hyperbilirubinemia subsequently (probability < 1%). In the remaining 77 (36.1%) infants, with TSB >6 mg/dl, subsequent hyperbilirubinemia developed in 21 (27.2%) (sensitivity 95%, specificity 70.6%, positive predictive value 27.2%, negative predictive value 99.3%, likelihood ratio of positive test 3.23 and likelihood ratio of negative test 0.07). Babies with TSB levels higher than 6 mg/dl had a significant risk of developing hyperbilirubinemia (relative risk 38; 95% confidence interval 6-1675).
Conclusion: A TSB level of < or = 6 mg/dl at 24 +/- 6 hr of life predicted neonates who would not develop hyperbilirubinemia.
Similar articles
-
[Predictive ability of a predischarge hour-specific serum bilirubin for hyperbilirubinemia in full term infants].Minerva Pediatr. 2007 Jun;59(3):183-9. Minerva Pediatr. 2007. PMID: 17519862 Italian.
-
Efficacy of oral phenobarbitone in term "at risk" neonates in decreasing neonatal hyperbilirubinemia: a randomized double-blinded, placebo controlled trial.Indian Pediatr. 2004 Apr;41(4):327-32. Indian Pediatr. 2004. PMID: 15123861 Clinical Trial.
-
Transcutaneous bilirubin in the pre-term infants.J Med Assoc Thai. 2007 Sep;90(9):1803-8. J Med Assoc Thai. 2007. PMID: 17957922
-
Hyperbilirubinemia in the term newborn.Am Fam Physician. 2002 Feb 15;65(4):599-606. Am Fam Physician. 2002. PMID: 11871676 Review.
-
Point of care testing: transcutaneous bilirubinometry in neonates.Clin Biochem. 2009 Feb;42(3):143-9. doi: 10.1016/j.clinbiochem.2008.09.106. Epub 2008 Oct 2. Clin Biochem. 2009. PMID: 18929553 Review.
Cited by
-
Prediction of Neonatal Hyperbilirubinemia Using 1st Day Serum Bilirubin Levels.Indian J Pediatr. 2019 Feb;86(2):174-176. doi: 10.1007/s12098-018-2633-0. Epub 2018 Feb 15. Indian J Pediatr. 2019. PMID: 29450817
-
Ensemble learning for the early prediction of neonatal jaundice with genetic features.BMC Med Inform Decis Mak. 2021 Dec 1;21(1):338. doi: 10.1186/s12911-021-01701-9. BMC Med Inform Decis Mak. 2021. PMID: 34852805 Free PMC article.
-
Fetomaternal Outcome Among the Pregnant Women Subject to the Induction of Labor.Cureus. 2021 May 24;13(5):e15216. doi: 10.7759/cureus.15216. Cureus. 2021. PMID: 34178535 Free PMC article.
-
Assessment of adherence level for neonatal hyperbilirubinemia management by various physicians in Iraq: a multi-clinic study.F1000Res. 2020 Jun 3;9:504. doi: 10.12688/f1000research.24258.1. eCollection 2020. F1000Res. 2020. PMID: 32765841 Free PMC article.
-
A review of existing neonatal hyperbilirubinemia guidelines in Indonesia.F1000Res. 2023 Nov 13;11:1534. doi: 10.12688/f1000research.110550.2. eCollection 2022. F1000Res. 2023. PMID: 38025296 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Medical